More
    Guided Solutions - Connecting Talent With Innovation/div>

    FDA grants 510(k) clearance for Allevion Medical’s Vantage system

    Allevion Medical has secured the US Food and Drug Administration (FDA) 510(k) clearance for Vantage, a fully disposable and sterile system intended to simplify and improve minimally invasive spinal decompression procedures. Vantage allows for targeted...

    FDA grants 510(k) clearance for Allevion Medical’s Vantage system

    Allevion Medical has secured the US Food and Drug Administration (FDA) 510(k) clearance for Vantage, a fully disposable and sterile system intended to simplify...

    Lifebloom secures €8M for exoskeleton walking therapy

    French medtech innovator Lifebloom has successfully closed an €8 million funding round, injecting significant capital to advance its robotic exoskeleton therapy for mobility restoration....

    HEPTA Medical closes a €10M oversubscribed Series A

    HEPTA MEDICAL, a medical technology company developing a minimally invasive treatment for early-stage lung cancer, announced the closing of its €10 million oversubscribed Series...

    GS MedTech Funding Tracker – Blackstone, Diagens, and more

    From a record-setting Life Sciences fund to growth rounds in AI and neurotech, this week’s MedTech deals are fueling clinical validation and global expansion....
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    Data supports Boston Scientific Watchman FLX in stroke reduction

    Boston Scientific announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system. Watchman FLX, Boston Scientific’s left atrial appendage closure (LAAC) device, reduces...

    iPerf enrolls first patient in study of dual-flow femoral artery cannula

    iPerf announced the first-in-human use of its new dual-flow femoral arterial cannula device. Lyon, France-based iPerf designed its device to integrate an additional flow...

    Providence Medical enrols first patients in CORUS-LX system trial

    Providence Medical Technology has enrolled the first subjects in its prospective, randomised controlled trial (RCT) assessing the CORUS-LX system to treat degenerative lumbosacral disease. The...

    Senseonics reports sustained year-long CGM implant outcomes

    Senseonics announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM. Real-world evidence demonstrated the long-term performance and positive...

    Innovation

    Regulatory Approvals

    FDA grants 510(k) clearance for Allevion Medical’s Vantage system

    Allevion Medical has secured the US Food and Drug Administration (FDA) 510(k) clearance for Vantage, a fully disposable and sterile system intended to simplify...

    Lifebloom secures €8M for exoskeleton walking therapy

    French medtech innovator Lifebloom has successfully closed an €8 million funding round, injecting significant capital to advance its robotic exoskeleton therapy for mobility restoration....

    HEPTA Medical closes a €10M oversubscribed Series A

    HEPTA MEDICAL, a medical technology company developing a minimally invasive treatment for early-stage lung cancer, announced the closing of its €10 million oversubscribed Series...

    GS MedTech Funding Tracker – Blackstone, Diagens, and more

    From a record-setting Life Sciences fund to growth rounds in AI and neurotech, this week’s MedTech deals are fueling clinical validation and global expansion....

    M&A

    Archives

    Latest articles